{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:43:23Z","timestamp":1761129803768},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.17269\/s41997-020-00439-7","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T16:04:54Z","timestamp":1605801894000},"page":"939-944","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective"],"prefix":"10.17269","volume":"111","author":[{"given":"Philippe","family":"De Wals","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maziar","family":"Divangahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"439_CR1","unstructured":"Aaby, P., Stabell Benn, C., Flanagan, K.L., Klein SL, Kollmann TB, Lynn DL, et al. (2020). The non-specific and sex-differential effects of vaccines. Nature Rev Immunol. Available at: https:\/\/www.nature.com\/articles\/s41577-020-0338-x.pdf. Accessed 30 Sept 2020."},{"key":"439_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts, R. J. W., Moorlag, S. J. C. F. M., Novakovic, B., Wang, S. Y., Oosting, M., Kumar, V., et al. (2018). BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host & Microbe, 23, 89\u2013100.e5.","journal-title":"Cell Host & Microbe"},{"key":"439_CR3","unstructured":"Canadian Institute for Health Information. (2020). Health workforce 2018. Available at : https:\/\/www.cihi.ca\/en\/health-workforce. Accessed 30 Sept 2020."},{"key":"439_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","volume":"36","author":"T Cernuschi","year":"2018","unstructured":"Cernuschi, T., Malvolti, S., Nickels, E., Friede, M., et al. (2018). Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: A global assessment of demand and supply balance. Vaccine, 36, 498\u2013506.","journal-title":"Vaccine"},{"key":"439_CR5","unstructured":"CIQ - Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec. (2016). Avis sur la pertinence de la r\u00e9introduction du vaccin bacille Calmette-Gu\u00e9rin (BCG) au Nunavik dans le contexte d\u2019une recrudescence de la tuberculose. Qu\u00e9bec, Institut national de sant\u00e9 publique. Available at : https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/2179_pertinence_reintroduction_vaccin_tuberculose_nunavik.pdf. Accessed 30 Sept 2020."},{"key":"439_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/INF.0000000000002230","volume":"38","author":"N Curtis","year":"2019","unstructured":"Curtis, N. (2019). BCG vaccination and all-cause neonatal mortality. The Pediatric Infectious Disease Journal, 38, 195\u2013197.","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"439_CR7","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/cid\/civ144","volume":"60","author":"MJ de Castro","year":"2015","unstructured":"de Castro, M. J., Pardo-Seco, J., & Martin\u00f3n-Torres, F. (2015). Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis. Clinical Infectious Diseases, 60, 1611\u20131619.","journal-title":"Clinical Infectious Diseases"},{"key":"439_CR8","unstructured":"De Wals, P., Rousseau, M. C., Menzie, D., & Divangahi, M. (2020). Le vaccin BCG pourrait-il apporter une protection contre la COVID-19 ? Qu\u00e9bec: Institut national de sant\u00e9 publique du Qu\u00e9bec. Available at: https:\/\/www.inspq.qc.ca\/publications\/2993-vaccin-bcg-protection-contre-covid19. Accessed 30 Sept 2020."},{"key":"439_CR9","unstructured":"De Wals, P. (2020). Fardeau des infections respiratoires et des otites et impact du programme d\u2019immunisation contre le pneumocoque dans la population du Nunavik. Qu\u00e9bec: Institut national de sant\u00e9 publique. Available at: https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/2677_fardeau_infections_respiratoire_population_nunavik.pdf. Accessed 30 Sept 2020."},{"key":"439_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/erv.10.151","volume":"10","author":"P De Wals","year":"2011","unstructured":"De Wals, P. (2011). Optimizing the acceptability, effectiveness and costs of immunization programs: The Quebec experience. Expert Review of Vaccines, 10, 55\u201362.","journal-title":"Expert Review of Vaccines"},{"key":"439_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41577-018-0070-y","volume":"18","author":"M Divangahi","year":"2018","unstructured":"Divangahi, M. (2018). Are tolerance and training required to end TB? Nature Reviews. Immunology, 18, 661\u2013663.","journal-title":"Nature Reviews. Immunology"},{"issue":"20","key":"439_CR12","doi-asserted-by":"publisher","first-page":"31139","DOI":"10.1016\/j.cell.2020.08.051","volume":"S0092-8674","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. J., Tsilika, M., Moorlag, S., Antonakos, N., Kotsaki, A., Dom\u00ednguez-Andr\u00e9s, J., et al. (2020). Activate: Randomized clinical trial of BCG vaccination against infection in the elderly. Cell, S0092-8674(20), 31139\u201331139. https:\/\/doi.org\/10.1016\/j.cell.2020.08.051.","journal-title":"Cell"},{"key":"439_CR13","first-page":"1025","volume":"160","author":"S Grzybowski","year":"1999","unstructured":"Grzybowski, S., & Allen, E. A. (1999). Tuberculosis: 2. History of the disease in Canada. CMAJ, 160, 1025\u20131028.","journal-title":"CMAJ"},{"key":"439_CR14","first-page":"2122","volume":"45","author":"S Haahr","year":"2016","unstructured":"Haahr, S., Michelsen, S. W., Andersson, M., Bjorn-Mortensen, K., Soborg, B., Wohlfahrt, J., et al. (2016). Non-specific effects of BCG vaccination on morbidity among children in Greenland: a population-based cohort study. International Journal of Epidemiology, 45, 2122\u20132130.","journal-title":"International Journal of Epidemiology"},{"key":"439_CR15","doi-asserted-by":"crossref","unstructured":"Higgins, J. P., Soares-Weiser, K., L\u00f3pez-L\u00f3pez, J. A., Kakourou, A., Chaplin, K., Christensen, H., et al. (2016). Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ, 355, i5170.","DOI":"10.1136\/bmj.i5170"},{"key":"439_CR16","doi-asserted-by":"crossref","unstructured":"Ismail, S. J., Langley, J. M., Harris, T. M., Warshawsky, B. F., Desai, S., & FarhangMehr, M. (2010). Canada\u2019s National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization. Vaccine, 28(Suppl 1), A58\u2013A63.","DOI":"10.1016\/j.vaccine.2010.02.035"},{"key":"439_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/INF.0000000000002198","volume":"38","author":"K Jayaraman","year":"2019","unstructured":"Jayaraman, K., Adhisivam, B., Nallasivan, S., Krishnan, R. G., Kamalarathnam, C., Bharathi, M., et al. (2019). Two randomized trials of the effect of the Russian strain of Bacillus Calmette-Gu\u00e9rin alone or with oral polio vaccine on neonatal mortality in infants weighing <2000\u2009g in India. The Pediatric Infectious Disease Journal, 38, 198\u2013202.","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"439_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann, E., Sanz, J., Dunn, J. L., Khan, N., Mendon\u00e7a, L. E., Pacis, A., et al. (2018). BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell, 172, 176\u2013190. e19.","journal-title":"Cell"},{"key":"439_CR19","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1172\/JCI128877","volume":"129","author":"SA Khader","year":"2019","unstructured":"Khader, S. A., Divangahi, M., Hanekom, W., Hill, P. C., Maeurer, M., Makar, K. W., et al. (2019). Targeting innate immunity for tuberculosis vaccination. The Journal of Clinical Investigation, 129, 3482\u20133491.","journal-title":"The Journal of Clinical Investigation"},{"key":"439_CR20","doi-asserted-by":"crossref","unstructured":"Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L. A., Ifrim, D. C., Saeed, S., et al. (2012). Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proceedings of the National Academy of Sciences of the United States of America, 109, 17537\u201317542.","DOI":"10.1073\/pnas.1202870109"},{"key":"439_CR21","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","volume":"212","author":"J Leentjens","year":"2015","unstructured":"Leentjens, J., Kox, M., Stokman, R., Gerretsen, J., Diavatopoulos, D. A., van Crevel, R., et al. (2015). BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: A randomized, placebo-controlled pilot study. The Journal of Infectious Diseases, 212, 1930\u20131938.","journal-title":"The Journal of Infectious Diseases"},{"key":"439_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/iju.13538","volume":"25","author":"J Miyazaki","year":"2018","unstructured":"Miyazaki, J., Onozawa, M., Takaoka, E., & Yano, I. (2018). Bacillus Calmette-Gu\u00e9rin strain differences as the basis for immunotherapies against bladder cancer. International Journal of Urology, 25, 405\u2013413.","journal-title":"International Journal of Urology"},{"key":"439_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41479-017-0041-2","volume":"9","author":"E Muthumbi","year":"2017","unstructured":"Muthumbi, E., Lowe, B. S., Muyodi, C., Getambu, E., Gleeson, F., & Scott, J. A. G. (2017). Risk factors for community-acquired pneumonia among adults in Kenya: A case-control study. Pneumonia, 9, 17.","journal-title":"Pneumonia"},{"key":"439_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12889-015-1497-8","volume":"15","author":"V Nankabirwa","year":"2015","unstructured":"Nankabirwa, V., Tumwine, J. K., Mugaba, P. M., Tyllesk\u00e4r, T., Sommerfelt, H., & PROMISE- EBF Study Group. (2015). Child survival and BCG vaccination: A community based prospective cohort study in Uganda. BMC Public Health, 15, 175.","journal-title":"BMC Public Health"},{"key":"439_CR25","volume-title":"Resultats des exp\u00e9riences de vaccination par le BCG poursuivies dans le Norrbotten (Su\u00e8de) (Septembre 1927\u2013D\u00e9cembre 1931). Vaccination Pr\u00e9ventive de Tuberculose","author":"C N\u00e4slund","year":"1932","unstructured":"N\u00e4slund, C. (1932). Resultats des exp\u00e9riences de vaccination par le BCG poursuivies dans le Norrbotten (Su\u00e8de) (Septembre 1927\u2013D\u00e9cembre 1931). Vaccination Pr\u00e9ventive de Tuberculose. Paris: Institut Pasteur, Rapports et Documents."},{"key":"439_CR26","unstructured":"NCT 04439045. (2020). Efficacy and safety of VPM1002 in reducing SARS-CoV-2 (COVID-19) infection rate and severity (COBRA). Washington, DC: Clinical.Trials.gov, US National Library of Medicine. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04439045. Accessed 30 Sept 2020."},{"key":"439_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-020-0285-6","volume":"4","author":"MG Netea","year":"2020","unstructured":"Netea, M. G., Dom\u00ednguez-Andr\u00e9s, J., Barreiro, L. B., Chavakis, T., Divangahi, M., Fuchs, E., et al. (2020a). Defining trained immunity and its role in health and disease. Nature Reviews Immunology, 4, 1\u201314. https:\/\/doi.org\/10.1038\/s41577-020-0285-6 Online ahead of print.","journal-title":"Nature Reviews Immunology"},{"key":"439_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","volume":"181","author":"MG Netea","year":"2020","unstructured":"Netea, M. G., Giamarellos-Bourboulis, E. J., Dom\u00ednguez-Andr\u00e9s, J., Curtis, N., van Crevel, R., van de Veerdonk, F. L., et al. (2020b). Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell, 181, 969\u2013977.","journal-title":"Cell"},{"key":"439_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","volume":"8","author":"NE Nieuwenhuizen","year":"2017","unstructured":"Nieuwenhuizen, N. E., Kulkarni, P. S., Shaligram, U., Cotton, M. F., Rentsch, C. A., Eisele, B., et al. (2017). The recombinant Bacille Calmette-Gu\u00e9rin vaccine VPM1002: Ready for clinical efficacy testing. Frontiers in Immunology, 8, 1147.","journal-title":"Frontiers in Immunology"},{"key":"439_CR30","doi-asserted-by":"publisher","first-page":"151600","DOI":"10.1016\/j.anndiagpath.2020.151600","volume":"48","author":"G Nuovo","year":"2020","unstructured":"Nuovo, G., Tili, E., Suster, D., Matys, E., Hupp, L., & Magro, C. (2020). Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine. Annals of Diagnostic Pathology, 48, 151600. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151600.","journal-title":"Annals of Diagnostic Pathology"},{"key":"439_CR31","unstructured":"Public Health Agency of Canada. (2020). Canadian Immunization Guide. Ottawa: Government of Canada. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/canadian-immunization-guide.html. Accessed 30 Sept 2020."},{"key":"439_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","volume":"11","author":"G Redelman-Sidi","year":"2014","unstructured":"Redelman-Sidi, G., Glickman, M. S., & Bochner, B. H. (2014). The mechanism of action of BCG therapy for bladder cancer--a current perspective. Nature Reviews. Urology, 11, 153\u2013162.","journal-title":"Nature Reviews. Urology"},{"key":"439_CR33","first-page":"207","volume":"91","author":"M Ricc\u00f2","year":"2020","unstructured":"Ricc\u00f2, M., Gualerzi, G., Ranzieri, S., & Bragazzi, N. L. (2020). Stop playing with data: There is no sound evidence that Bacille Calmette-Gu\u00e9rin may avoid SARS-CoV-2 infection (for now). Acta Biomed, 91, 207\u2013213.","journal-title":"Acta Biomed"},{"key":"439_CR34","first-page":"695","volume":"46","author":"A Rieckmann","year":"2017","unstructured":"Rieckmann, A., Villumsen, M., S\u00f8rup, S., Haugaard, L. K., Ravn, H., Roth, A., et al. (2017). Vaccinations against smallpox and tuberculosis are associated with better long-term survival: A Danish case-cohort study 1971-2010. International Journal of Epidemiology, 46, 695\u2013705.","journal-title":"International Journal of Epidemiology"},{"key":"439_CR35","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1016\/j.vaccine.2017.06.064","volume":"35","author":"MC Rousseau","year":"2017","unstructured":"Rousseau, M. C., Conus, F., K\u00e2, K., El-Zein, M., Parent, M. \u00c9., & Menzies, D. (2017). Bacillus Calmette-Gu\u00e9rin (BCG) vaccination patterns in the province of Qu\u00e9bec, Canada, 1956-1974. Vaccine, 35, 4777\u20134784.","journal-title":"Vaccine"},{"issue":"20","key":"439_CR36","doi-asserted-by":"publisher","first-page":"31235","DOI":"10.1016\/j.cell.2020.09.038","volume":"S0092-8674","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., et al. (2020). Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell, S0092-8674(20), 31235\u201331236. https:\/\/doi.org\/10.1016\/j.cell.2020.09.038.","journal-title":"Cell"},{"key":"439_CR37","unstructured":"SAGE Working Group on BCG Vaccines and WHO Secretariat. (2017). Report on BCG vaccine use for protection against mycobacterial infections including tuberculosis, leprosy, and other nontuberculosis mycobacteria (NTM) infections. Geneva: WHO. Available at: https:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/1_BCG_report_revised_version_online.pdf?ua=1. Accessed 30 Sept 2020."},{"key":"439_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.clinthera.2013.01.007","volume":"35","author":"F Shann","year":"2013","unstructured":"Shann, F. (2013). Nonspecific effects of vaccines and the reduction of mortality in children. Clinical Therapeutics, 35, 109\u2013114.","journal-title":"Clinical Therapeutics"},{"key":"439_CR39","doi-asserted-by":"publisher","first-page":"E404","DOI":"10.3390\/vaccines8030404","volume":"8","author":"DE Speiser","year":"2020","unstructured":"Speiser, D. E., & Bachmann, M. F. (2020). COVID-19: Mechanisms of vaccination and immunity. Vaccines (Basel), 8, E404. https:\/\/doi.org\/10.3390\/vaccines8030404.","journal-title":"Vaccines (Basel)"},{"key":"439_CR40","unstructured":"StatCan. (2020). Statistics on indigenous people. Ottawa: Government of Canada. Available at: https:\/\/www.statcan.gc.ca\/eng\/subjects-start\/indigenous_peoples. Accessed 30 Sept 2020."},{"key":"439_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/archdischild-2016-310760","volume":"102","author":"LG Stensballe","year":"2017","unstructured":"Stensballe, L. G., S\u00f8rup, S., Aaby, P., Benn, C. S., Greisen, G., Jeppesen, D. L., et al. (2017). BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial. Archives of Disease in Childhood, 102, 224\u2013231.","journal-title":"Archives of Disease in Childhood"},{"key":"439_CR42","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/cid\/civ452","volume":"61","author":"L Storgaard","year":"2015","unstructured":"Storgaard, L., Rodrigues, A., Martins, C., Nielsen, B. U., Ravn, H., Benn, C. S., et al. (2015). Development of BCG scar and subsequent morbidity and mortality in rural Guinea-Bissau. Clinical Infectious Diseases, 61, 950\u2013959.","journal-title":"Clinical Infectious Diseases"},{"key":"439_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.publhealth.29.020907.090821","volume":"29","author":"J Wakefield","year":"2008","unstructured":"Wakefield, J. (2008). Ecological studies revisited. Annual Review of Public Health, 29, 75\u201390. https:\/\/doi.org\/10.1146\/annurev.publhealth.29.020907.090821.","journal-title":"Annual Review of Public Health"},{"key":"439_CR44","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41467-019-08659-3","volume":"10","author":"J Walk","year":"2019","unstructured":"Walk, J., de Bree, L. C. J., Graumans, W., Stoter, R., van Gemert, G. J., van de Vegte-Bolmer, M., et al. (2019). Outcomes of controlled human malaria infection after BCG vaccination. Nature Communications, 10, 874.","journal-title":"Nature Communications"},{"key":"439_CR45","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020). Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA, 324, 782\u2013793.","journal-title":"JAMA"},{"key":"439_CR46","doi-asserted-by":"publisher","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020). COVID-19 pathophysiology: A review. Clinical Immunology, 215, 108427. https:\/\/doi.org\/10.1016\/j.clim.2020.108427.","journal-title":"Clinical Immunology"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-020-00439-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.17269\/s41997-020-00439-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-020-00439-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T15:17:45Z","timestamp":1607613465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.17269\/s41997-020-00439-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.17269\/s41997-020-00439-7","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}